Orphan Drug Designations and Approvals List as of 12‐01‐2014

First Page		Document Content
Date: 2015-01-09 02:11:43 Technology Drug discovery Orphan drug Pharmaceuticals policy Methadone Sigma-Tau Antithrombin Novartis Chiron Corporation Pharmaceutical industry Chemistry Ketones		Orphan Drug Designations and Approvals List as of 12‐01‐2014 Add to Reading List Source URL: www.hrsa.gov Download Document from Source Website File Size: 1,74 MB Share Document on Facebook

	Biomolecular Interaction and The Interactome.doc DocID: 1pQMx - View Document
	Domestic Sales Outsourcing Agreement for Recombinant Human Antithrombin Preparation Signed Tokyo, Japan, July 30, The Japan Blood Products Organization (head office: Tokyo, Japan, President and representative di DocID: 1lLMs - View Document
	Paris, 19 MayPress releaseGTC BIOTHERAPEUTICS Inc., a LFB group company, granted protection until 2027 on broad transgenic protein production patent, and is also granted new patent on recombinant antithrombin pro DocID: 1aPBm - View Document
	Routine Coagulation Reagents Activated Partial Thromboplastin Time (aPTT) Antithrombin III (ATIII) Prothrombin Time (PT) Thrombin Time (TT) Fibrinogen DocID: 1aOgJ - View Document
	HAEMATOLOGIC TECHNOLOGIES INCResearch Reagents Catalog DocID: 1apfC - View Document